But wouldn't the Market be somewhat aware of the expected delay...

First 140 Last

Share
Profile

Follow
goggledog

7,060 Posts.

218

19/08/16

22:12

Post #: 18562969
Share

Originally posted by asb83 ↑

The slow rate of conversion from contract to cash has rightly justified the share price being hammered from its lofty heights. They signed $1.4m in contracts back in November and apparently they still won't be showing on the Q2 cash flow - 8 months later. It definitely makes the investment community question the nature of those contracts.

I work in IT and finance and know how long and drawn out processes can be, especially when dealing with large corporations. To me it looks like they signed the contracts in Q4 with the promise that the product will have additional functionality/meet certain specifications from the clients, which they then went away and built in Q1 and then deployed in Q2, with revenue only starting to be recognised in Q2. Hence the big delay from contract to cash. They did spell out 5-6 months for cash conversion in previous reports, so it appears they are a few months behind on that guidance.

A lot of people are sitting on the sidelines with this one. Any sign that progress is being made through increased cash flow and bookings will see this lift. A fortune 500 client signing a $500k contract is the equivalent of us going to the shops and buying $10 worth of groceries. These companies spend a fortune on recruiting and there aren't many players specialising in this method of recruiting. The fact that they have signed some big clients shows that companies are looking at new ways to recruit. They would only need 10-15 big clients and a handful of smaller clients to be profitable. From the value of their existing contracts, they are 1/3rd of the way there.

Expand

But wouldn't the Market be somewhat aware of the expected delay between conversion of contract to cash and allow for this in it's valuation of 1PG?

1PG Price at posting: 28.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 140 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

But wouldn't the Market be somewhat aware of the expected delay...

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News